This website uses cookies Please find more information about the use of cookies by reading our cookies policy and the cookies declaration below (available when clicking on “Show details”). You may enable / disable cookies according to your preferences using the below menu. OK Strictly Necessary Cookies Performance Functionality Third Party Cookies Show details WE ARE INNOVATIVE Technologies & Product Development With the application of innovative techniques and advanced technologies, Pharmathen aims to provide Life Cycle Management solutions for branded pharma, as well as to develop and establish new technology platforms and provide optimized pharmaceutical products to patients. WE ARE PHARMATHEN Our People Our people are a core aspect of Pharmathen’ s competitive advantage. We attract and retain key talents with a high level of expertise and know-how who drive our business forward. OUR BUSINESS MODELS & PARTNERS Worldwide Presence Through a carefully selected network of licensors, distributors, and affiliates, Pharmathen operates in all 6 continents, marketing the group’s existing portfolio and, more importantly, shaping the future for the products under development. OUR PORTFOLIO Products Pharmathen produces a variety of products using innovative and advanced technologies. For a full list of the product portfolio, please follow the link below. Terms of use Data Protection Πολιτική Προστασίας Προσωπικών Δεδομένων Cookie Policy Contact us Change your cookie consent Annual Modern Slavery Statement Copyright © Pharmathen SA 2018. All rights reserved

GMP APPROVALS & CERTIFICATIONS OUR MANUFACTURING SITES Our global expansion is mostly covered by our two state-of-the-art manufacturing facilities, with our largest one in Rodopi being recently approved by US FDA and other national and international authorities; with a total production capacity of over 3.8bn tablets, 2.2 bn capsules, 2.5m ampoules for injection and with over 20.400m2 of manufacturing space and 5.440 m2 of warehousing space, we are ranked among the top quality manufacturers based in Europe. At a glance MANUFACTURING SITE SAPES RODOPI FDA approved In operation since June 2010 Designed by German Group M&W 17.000 m2 in a strategic location New state-of-the-art facility launched in 2010 Production capacity: 3bn tablets 2bn capsules Environmentally friendly investment One of the largest employers in the region MANUFACTURING SITE PALLINI ATTICA 3.600 m2 Pallini plant 2.000 m2 Aspropyrgos warehouse Manufactures solid dosage forms and parenteral dosage forms GMP approvals Production capacity: 800m tablets 200m capsules 4m amp trials for injections Click on the image to view gallery Terms of use Data Protection Πολιτική Προστασίας Προσωπικών Δεδομένων Cookie Policy Contact us Change your cookie consent Annual Modern Slavery Statement Copyright © Pharmathen SA 2018. All rights reserved